Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Non-current contingent consideration Contingent Consideration, Noncurrent, Fair Value Contingent Consideration, Noncurrent, Fair Value Schedule of Carrying Values of Indefinite Lived Intangible Assets Intangible Asset and Goodwill [Table Text Block] Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Range [Domain] Statistical Measurement [Domain] Title of 12(b) Security Title of 12(b) Security On-X On X [Member] On-X [Member] Net (loss) income allocated to common stockholders Net Income (Loss) Available to Common Stockholders, Diluted Subsequent Event Subsequent Event [Member] Document Fiscal Year Focus Document Fiscal Year Focus Anthony B. Semedo [Member] Anthony B. Semedo Acquisition-related cost, expense Business Combination, Acquisition-Related Cost, Expense Adjustment to Compensation, Amount Adjustment to Compensation Amount Segment Reporting [Abstract] Segment Reporting [Abstract] Common stock $0.01 par value per share, 75,000 shares authorized, 50,179 and 49,330 shares issued as of June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Accrued compensation Employee-related Liabilities, Current Per Clot Per Clot [Member] PerClot [Member] Restatement Determination Date Restatement Determination Date Medical devices Medical Devices [Member] Medical Devices [Member] Conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Proceeds from sale of assets Proceeds from Sale of Productive Assets Amendment Flag Amendment Flag Other intangibles, net Intangible Assets Other Than Acquired Technology [Member] Intangible Assets Other Than Acquired Technology [Member] Current liabilities: Liabilities, Current [Abstract] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Developed technology Developed Technology Rights [Member] Consignment inventory percentage Consignment Inventory Percentage Consignment inventory percentage. Additional Potential Cash Payment If Japan Or China Obtains Approval Additional Potential Cash Payment If Japan Or China Obtains Approval [Member] Additional Potential Cash Payment If Japan Or China Obtains Approval [Member] Consignment inventory Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross Following FDA Approval For AMDS Following Fda Approval For Amds [Member] Following FDA Approval For AMDS [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Entity Address, State or Province Entity Address, State or Province Foreign currency translation adjustments, net of tax Foreign currency translation adjustments gain (loss) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent PEO Total Compensation Amount PEO Total Compensation Amount Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Net other assets/liabilities acquired Business Combination, Recognized Identifiable Other Assets Acquired and Other Liabilities Assumed, Net Business Combination, Recognized Identifiable Other Assets Acquired and Other Liabilities Assumed, Net Basic (in shares) Basic weighted-average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Write-down of inventories and deferred preservation costs Write-Down of Deferred Preservation Costs and Inventories Amounts of the current period expense charged to cost of products and preservation services for the purpose of reducing deferred preservation costs and inventory, respectively, to amounts that approximate their net realizable value. Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Less: Accumulated amortization Internal-Use Software, Accumulated Amortization Internal-Use Software, Accumulated Amortization Internal-Use Software, net Software, Internal-Use [Policy Text Block] Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current Work-in-process Inventory, Work in Process, Net of Reserves Schedule of Internal-Use Software Schedule Of Internal-Use Software [Table Text Block] Schedule Of Internal-Use Software Term Loan Facility Term Loan Facility [Member] Term Loan Facility Entity Address, City or Town Entity Address, City or Town Authorized awards from approved stock incentive plans (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] From First Quarter of Fiscal Year 2025 and Thereafter From First Quarter of Fiscal Year 2025 and Thereafter [Member] From First Quarter of Fiscal Year 2025 and Thereafter Business Combination, Consideration Transferred [Abstract] Business Combination, Consideration Transferred [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Basis of Accounting Basis of Accounting, Policy [Policy Text Block] Endospan Option Endospan Option [Member] Endospan Option Acquired technology, net Net Carrying Value Intangible Asset, Finite-Lived, after Accumulated Amortization Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net (loss) income allocated to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Accumulated Amortization Intangible Asset, Finite-Lived, Accumulated Amortization Level 2 Fair Value, Inputs, Level 2 [Member] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] In-process research and development (“IPR&D”) Intangible Asset, Indefinite-Lived, Acquired Credit facility aggregate commitments Line of Credit Facility, Maximum Borrowing Capacity Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Less: Current portion of long-term debt Long-Term Debt, Current Maturities To Settle Endospan Debt Obligations To Settle Endospan Debt Obligations [Member] To Settle Endospan Debt Obligations Domestic UNITED STATES Subsequent Event Type [Axis] Subsequent Event Type [Axis] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] New Accounting Pronouncements and Not Yet Effective New Accounting Pronouncements, Policy [Policy Text Block] Schedule of Revenues, Cost of Products and Services, and Gross Margins for Operating Segments Segment Reporting [Table Text Block] If Prepayment Occurs Prior to July 18, 2027 If Prepayment Occurs Prior To July 18, 2027 [Member] If Prepayment Occurs Prior To July 18, 2027 Artivion Inc. And Starch Medical Inc. Artivion Inc. And Starch Medical Inc. [Member] Artivion, Inc. And Starch Medical, Inc. [Member] Schedule of Reconciliation of Changes in Fair Value of Level 3 Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Intangible assets, net Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill Total debt Long-term debt Long-Term Debt Aggregate grant date market value Share Based Compensation Arrangement By Share Based Payment Award Other Than Options, Grant Date Fair Value Market value of share based compensation arrangement by share based payment award other than options granted during the period. Document Period End Date Document Period End Date Changes in operating assets and liabilities, net of acquisition: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net cash flows used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Debt instrument, face amount Debt Instrument, Face Amount Security Exchange Name Security Exchange Name Treasury stock, at cost, 1,487 shares as of June 30, 2026 ‎and December 31, 2025 Treasury Stock, Common, Value Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Price of acquisition, expected Business Combination, Price of Acquisition, Expected FDA Approval PMA for AMDS FDA Approval PMA for AMDS [Member] FDA Approval PMA for AMDS Senior Secured, Interest-Only, Credit Facilities Senior Secured, Interest-Only, Credit Facilities [Member] Senior Secured, Interest-Only, Credit Facilities Total liabilities Liabilities, Fair Value Disclosure Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Consolidation Items [Domain] Consolidation Items [Domain] Current maturities of operating leases Operating Lease, Liability, Current Accrued interest Interest Payable, Current Schedule of Amortization Expense Property, Plant, and Equipment [Table Text Block] (Loss) Income Per Common Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name (Loss) income per share Earnings Per Share [Abstract] Earnings Per Share [Abstract] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Schedule of Net Revenues by Product and Service Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Product and Service, Revenue [Table Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Geographical [Domain] Geographical [Domain] Total indefinite-lived intangible assets Intangible Asset, Excluding Goodwill, Indefinite-Lived Capital expenditures Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Weighted-average common shares outstanding: Weighted Average Number of Shares Outstanding, Basic [Abstract] Purchase Price Allocation Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block] Company Selected Measure Name Company Selected Measure Name Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Non-cash amortization of debt issuance costs Amortization of Debt Issuance Costs and Discounts Internal-use software Internal-Use Software, Before Accumulated Amortization Internal-Use Software, Before Accumulated Amortization Cash payment amount Interest Expense, Long-Term Debt Business Combination, Contingent Consideration, Type [Axis] Business Combination, Contingent Consideration, Type [Axis] Schedule of Indefinite-Lived Intangible Assets [Table] Intangible Asset, Indefinite-Lived [Table] Total principal debt Long-Term Debt, Gross Non-cash lease expense Noncash Lease Expense Noncash Lease Expense Contractual period Disposal Group, Including Discontinued Operation, Contractual Period Disposal Group, Including Discontinued Operation, Contractual Period Credit Facility [Domain] Credit Facility [Domain] Fair Value by Asset Class [Domain] Asset Class [Domain] Net cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Other receivables Other Receivables, Net, Current AMDS Obtained In China Amds Obtained In China [Member] AMDS Obtained In China [Member] Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Indefinite-lived Intangible Assets [Line Items] Intangible Asset, Indefinite-Lived [Line Items] Equity ownership percent Business Combination, Voting Equity Interest Acquired, Percentage Diluted (in shares) Diluted weighted-average common shares outstanding Weighted Average Number of Shares Outstanding, Diluted Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Estimated useful lives of the related assets Property, Plant, and Equipment, Useful Life Disposal Group Name [Domain] Disposal Group Name [Domain] Line of Credit Facility [Table] Line of Credit Facility [Table] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Deferred income taxes Deferred Income Taxes and Tax Credits Intercompany Loans Intercompany Loans [Member] Intercompany Loans Goodwill expected to be deductible for income tax purposes Business Combination, Goodwill, Expected Tax Deductible, Amount Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Gross margin Total gross margin Gross Profit Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Other Other Intangible Assets [Member] Cost of products and preservation services: Cost of Revenue [Abstract] Award Timing Predetermined Award Timing Predetermined [Flag] Treasury Stock Treasury Stock, Common [Member] Intangible Asset, Goodwill and Other [Abstract] Intangible Asset, Goodwill and Other [Abstract] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Level 1 Fair Value, Inputs, Level 1 [Member] Effective income tax rate expense Effective Income Tax Rate Reconciliation, Percent Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Indefinite-lived Intangible Assets, Major Class Name [Domain] Intangible Asset, Indefinite-Lived, Class [Domain] Conversion ratio Debt Instrument, Convertible, Conversion Ratio Effect of dilutive stock options and awards (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Triggering Event [Axis] Triggering Event [Axis] Triggering Event Inventory, Current [Table] Inventory, Current [Table] All Executive Categories All Executive Categories [Member] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Notes and loans receivable Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Antidilutive Securities [Axis] Antidilutive Securities [Axis] Increase in worldwide revenue, measurement preceding period Business Acquisition, Contingent Consideration Arrangements, Increase In Worldwide Revenue, Preceding Period Business Acquisition, Contingent Consideration Arrangements, Increase In Worldwide Revenue, Preceding Period Operating lease right-of-use assets, net Operating Lease, Right-of-Use Asset Cash Consideration Cash Consideration [Member] Cash Consideration Schedule of Computation of Basic and Diluted (Loss) Income Per Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Net assets acquired Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Segment Information Segment Reporting [Text Block] Minimum Minimum [Member] Expiration Date Trading Arrangement Expiration Date Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Stock Options And Awards Stock Options And Awards [Member] stock options and awards Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Schedule of Amortization Expense Intangible Asset, Finite-Lived, Amortization Expense [Table Text Block] Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Deferred preservation costs Deferred Preservation Costs Donated human tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. By federal law, human tissues cannot be bought or sold, so the preservation process is a manufacturing process that is accounted for using the same principles as inventory costing. Preservation costs consist primarily of direct labor and materials and indirect costs which are stated at the lower of cost or market value on a first in, first out basis and are deferred until revenue is recognized upon shipment of the tissue to an implanting facility. Contingent liability payment Disposal Group, Including Discontinued Operation, Contingent Liability Payment Disposal Group, Including Discontinued Operation, Contingent Liability Payment Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Disposal Group, Including Discontinued Operations [Line Items] Disposal Group, Including Discontinued Operations [Line Items] Contingent consideration Business Combination, Consideration Transferred, Liabilities Incurred Business Combination [Line Items] Business Combination [Line Items] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Proceeds from exercise of stock options and issuance of common stock Proceeds from Issuance of Common Stock Common stock, shares authorized (in shares) Common Stock, Shares Authorized Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Weighted Average Useful Life (Years) Intangible Asset, Finite-Lived, Useful Life Schedule of Product Information [Table] Nature of Operation, Product Information, Concentration of Risk [Table] Exercise Price Award Exercise Price Net cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Segment Reporting [Line Items] Segment Reporting [Line Items] Document Quarterly Report Document Quarterly Report Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segment [Domain] Segments [Domain] Debt Debt Disclosure [Text Block] Repayment of debt Repayments of Long-Term Debt Amortized to interest expense Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Less: Unamortized debt issuance costs Debt issuance costs, net Debt Issuance Costs, Net Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Business Combination [Table] Business Combination [Table] Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Measurement Input Type [Domain] Measurement Input Type [Domain] Secured Debt Secured Debt [Member] Debt instrument, extension period Debt Instrument, Extension Period Debt Instrument, Extension Period Endospan Loans Loans Receivable, Fair Value Disclosure Adoption Date Trading Arrangement Adoption Date Consideration for sale of assets Disposal Group, Including Discontinued Operation, Consideration Interest rate on amounts borrowed Debt Instrument, Interest Rate, Stated Percentage Counterparty Name [Domain] Counterparty Name [Domain] Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Triggering Event [Domain] Triggering Event [Domain] Triggering Event [Domain] ASSETS Assets [Abstract] Procurement contracts and agreements Contractual Rights [Member] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Insider Trading Policies and Procedures [Line Items] Other Proceeds from (Payment for) Other Financing Activity Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Prepaid expenses and other Prepaid Expense and Other Assets, Current General, administrative, and marketing Selling, General and Administrative Expense Patents Patents [Member] Business Combination [Domain] Business Combination [Domain] Ascyrus Medical LLC Ascyrus Medical Llc [Member] Ascyrus Medical LLC [Member] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Antidilutive shares (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Schedule of Goodwill by Reportable Segment Goodwill [Table Text Block] Entity Central Index Key Entity Central Index Key Additional paid-in capital Additional Paid in Capital, Common Stock All Adjustments to Compensation All Adjustments to Compensation [Member] Exchange Agreements Exchange Agreements [Member] Exchange Agreements Other Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Other Item Business Combination [Axis] Business Combination [Axis] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash flows used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Debt Instrument, net leverage ratio Debt Instrument, Net Leverage Ratio Debt Instrument, Net Leverage Ratio Buyer Deposits Buyer Deposits [Member] Buyer Deposits AMDS Obtained In Japan Amds Obtained In Japan [Member] AMDS Obtained In Japan [Member] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Income Statement [Abstract] Income Statement [Abstract] Employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Document Transition Report Document Transition Report Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Deferred tax assets, net Deferred Income Tax Assets, Net Operating expenses: Operating Expenses [Abstract] Non-current finance lease obligations Finance Lease, Liability, Noncurrent Intersegment Eliminations Intersegment Eliminations [Member] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets Intangible Asset, Finite-Lived [Table Text Block] Payments to acquire businesses, gross, including transaction bonuses Payments to Acquire Businesses, Gross, Including Transaction Bonuses Payments to Acquire Businesses, Gross, Including Transaction Bonuses Term Loan Facility and Revolving Credit Facility Term Loan Facility and Revolving Credit Facility [Member] Term Loan Facility and Revolving Credit Facility Credit facility margin Debt Instrument, Basis Spread on Variable Rate City Area Code City Area Code Variable Rate [Domain] Variable Rate [Domain] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] All Individuals All Individuals [Member] Payable Disposal Group, Including Discontinued Operation, Accounts Payable Name Forgone Recovery, Individual Name Finished goods Inventory, Finished Goods, Net of Reserves FDA Approval IDE for AMDS Fda Approval Ide For Amds [Member] FDA Approval IDE for AMDS [Member] Non-current contingent consideration Business Combination, Contingent Consideration, Liability, Noncurrent Endospan Endospan [Member] Endospan Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Starch Medical Inc. Starch Medical Inc. [Member] Starch Medical, Inc. [Member] Common stock value issued in business combination Business Combination, Consideration Transferred, Equity Interest Statement [Line Items] Statement [Line Items] Total assets Assets Entity [Domain] Entity [Domain] Business Combination [Abstract] Business Combination [Abstract] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Convertible Debt Convertible Debt [Member] EMEA Europe, the Middle East, and Africa Segments [Member] Europe, the Middle East, and Africa Segments Operating Segments Operating Segments [Member] Interest expense Interest Expense, Nonoperating Stock Compensation Share-Based Payment Arrangement [Text Block] Employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Proceeds from issuance of convertible debt Proceeds from Convertible Debt Impairment of indefinite lived intangible assets Intangible Asset, Excluding Goodwill, Indefinite-Lived, Impairment Loss PEO PEO [Member] Other comprehensive (loss) income: Statement of Other Comprehensive Income [Abstract] Preservation services Preservation Services [Member] Preservation Services [Member] Other long-term liabilities Other Liabilities, Noncurrent Goodwill Beginning balance Ending balance Goodwill Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Product Information [Line Items] Product Information [Line Items] Endospan acquisition Goodwill, Acquired During Period Exercise of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Notes receivable balance Financing Receivable, after Allowance for Credit Loss, Noncurrent Subsequent Event Type [Domain] Subsequent Event Type [Domain] Retained Deficit Retained Earnings [Member] Non-current maturities of operating leases Operating Lease, Liability, Noncurrent Taxes payable Taxes Payable, Current Total operating expenses Operating Expenses Revolving Credit Facility Revolving Credit Facility [Member] Money market funds Money Market Funds [Member] Cash and cash equivalents Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent Software, In-Development, Internally Developed, and Purchased Software, In-Development, Internally Developed, and Purchased [Member] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Delayed Draw Term Loan Facility Delayed Draw Term Loan Facility [Member] Delayed Draw Term Loan Facility Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Award Timing Disclosures [Line Items] Payments of debt issuance costs Payments of Debt Issuance Costs Contingent consideration receivable Disposal Group Including Discontinued Operation, Contingent Consideration Receivable Disposal Group Including Discontinued Operation, Contingent Consideration Receivable Schedule of Financial Instruments Measured at Fair Value Fair Value, by Balance Sheet Grouping [Table Text Block] Diluted (in usd per share) Diluted (loss) income per common share (in usd per share) Earnings Per Share, Diluted AMDS Contingent Consideration Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] Entity Current Reporting Status Entity Current Reporting Status Net cash flows provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Revolving Credit Facility Revolving Credit Facility1 [Member] Revolving Credit Facility1 Total Shareholder Return Amount Total Shareholder Return Amount Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets North America North America Segment [Member] North America Segment Amortization expense Intangible Asset, Finite-Lived, Amortization Expense Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Intangible Asset, Finite-Lived [Line Items] Intangible Asset, Finite-Lived [Line Items] Research and development Research and Development Expense Adjustments to reconcile net (loss) income to net cash from operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Identifiable intangible assets Intangible Asset, Finite-Lived, Acquired Endospan Loan Endospan Loan [Member] Endospan Loan Deferred compensation liability Deferred Compensation Liability, Classified, Noncurrent Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Net cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Total revenues Total revenues Revenue from Contract with Customer, Excluding Assessed Tax Line of credit facility, unused capacity, commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Credit Facilities Credit Facilities [Member] Credit Facilities Basic (loss) income per common share Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Inventories and Deferred Preservation Costs Inventory Disclosure [Text Block] Intangible Asset, Finite-Lived, Class [Axis] Intangible Asset, Finite-Lived, Class [Axis] Exercise of options Stock Issued During Period, Value, Stock Options Exercised Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Goodwill and Other Intangible Assets Intangible Asset and Goodwill [Text Block] Underlying Securities Award Underlying Securities Amount Revenue Recognition Revenue from Contract with Customer [Text Block] Unused borrowing capacity, fee percentage Debt Instrument, Unused Borrowing Capacity, Fee Percentage Debt Instrument, Unused Borrowing Capacity, Fee Percentage Raw materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves Other Payment for (Proceeds from) Other Investing Activity Exchange aggregate shares (In shares) Debt Conversion, Converted Instrument, Shares Issued Potential additional tax exposure Potential Additional Tax Exposure Potential Additional Tax Exposure Segment Reporting [Table] Segment Reporting [Table] Current portion of contingent consideration Business Combination, Contingent Consideration, Liability, Current Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Balance as of December 31, 2025 Balance as of June 30, 2026 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Operating (loss) income Operating Income (Loss) RSAs, RSUs And PSUs Restricted Stock Awards, Restricted Stock Units and Performance Stock Units [Member] Restricted Stock Awards, Restricted Stock Units, Preferred Stock Units For Period from Second Quarter To Fourth Quarter of Fiscal Year 2024 For Period from Second Quarter To Fourth Quarter of Fiscal Year 2024 [Member] For Period from Second Quarter To Fourth Quarter of Fiscal Year 2024 Current Fiscal Year End Date Current Fiscal Year End Date Proceeds from issuance of debt Proceeds from Issuance of Debt Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Acquisition of Ascyrus Acquisition of Endospan Business Combination [Text Block] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Equity compensation Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Debt prepayment premium Debt Instrument, Prepayment Premium Debt Instrument, Prepayment Premium Proceeds from issuance of debt, net Proceeds From Issuance Of Long-Term Debt, Net Of Draw Fee Proceeds From Issuance Of Long-Term Debt, Net Of Draw Fee Upon Our Receipt of Premarket Approval Upon Our Receipt of Premarket Approval [Member] Upon Our Receipt of Premarket Approval Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Credit Facilities, Convertible Senior Notes and Old Credit Facilities Credit Facilities, Convertible Senior Notes and Old Credit Facilities [Member] Credit Facilities, Convertible Senior Notes and Old Credit Facilities Pre-existing relationship gain (loss) on settlement Gain (Loss) On Settlement Of Financing Receivable Gain (Loss) On Settlement Of Financing Receivable Common stock, shares issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Treasury stock at cost, shares (in shares) Beginning balance, treasury stock (in shares) Ending balance, treasury stock (in shares) Treasury Stock, Common, Shares Equity Components [Axis] Equity Components [Axis] Products and Services [Domain] Product and Service [Domain] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Entity Interactive Data Current Entity Interactive Data Current Variable Rate [Axis] Variable Rate [Axis] Current portion of finance lease obligations Finance Lease, Liability, Current Period of required contingent consideration Business Combination, Contingent Consideration, Period Business Combination, Contingent Consideration, Period Deferred tax liabilities, net Deferred Income Tax Liabilities, Net Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Small Business Entity Small Business Comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Termination Date Trading Arrangement Termination Date Weighted-average amortization period for the amortizable intangible assets Intangible Asset, Finite-Lived, Acquired, Weighted-Average Amortization Period Property, Plant, and Equipment [Line Items] Property, Plant, and Equipment [Line Items] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Sale of PerClot Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Other current liabilities Other Liabilities, Current Other long-term assets Other Assets, Noncurrent Document Type Document Type Acquisition of Endospan, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Accrued expenses Accrued Liabilities, Current Fair Value as of Grant Date Award Grant Date Fair Value Gain from sale of non-financial assets Gain (Loss) on Disposition of Assets Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Arrangement Duration Trading Arrangement Duration Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Proceeds from issuance of long-term debt, net Proceeds from Issuance of Long-Term Debt Local Phone Number Local Phone Number Consolidation Items [Axis] Consolidation Items [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name (Loss) income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Commitments and contingencies Commitments and Contingencies Gross Carrying Value Intangible Asset, Finite-Lived, before Accumulated Amortization Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] APAC Asia Pacific Segment [Member] Asia Pacific Segment Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Accounts payable, accrued expenses, and other liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Business Combinations Business Combination [Policy Text Block] Goodwill [Roll Forward] Goodwill [Roll Forward] Counterparty Name [Axis] Counterparty Name [Axis] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Intangible Asset, Finite-Lived, Class [Domain] Intangible Asset, Finite-Lived, Class [Domain] Trade name Trade Names [Member] Inventories Inventories Inventory, Net Award Type [Domain] Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Financial Instruments Fair Value Disclosures [Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] New Delayed Draw Term Loan Facility New Delayed Draw Term Loan Facility [Member] New Delayed Draw Term Loan Facility PEO Name PEO Name Additional Endospan Loan Additional Endospan Loan [Member] Additional Endospan Loan Geographical [Axis] Geographical [Axis] Payment for contingent consideration liability, financing activities Payment for Contingent Consideration Liability, Financing Activities Long-Lived Asset, Class [Axis] Long-Lived Asset, Class [Axis] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Contingent consideration, measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Legal Entity [Axis] Legal Entity [Axis] Interest expense Interest Expense, Debt Schedule of Intangible Asset Acquired Business Combination, Intangible Asset, Acquired, Finite-Lived and Indefinite-Lived [Table Text Block] Cash and cash equivalents beginning of period Cash and cash equivalents end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Customer lists and relationships Customer Lists [Member] Schedule of Finite-Lived Intangible Assets [Table] Intangible Asset, Finite-Lived [Table] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Base Rate Base Rate [Member] Products Products [Member] Products [Member] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Initial value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Debt Instrument [Axis] Debt Instrument [Axis] Cash consideration Payments to Acquire Businesses, Gross Non-cash compensation Share-Based Payment Arrangement, Noncash Expense ESPP, percentage of market price for eligible employees Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Disposal Group Name [Axis] Disposal Group Name [Axis] Schedule of Short-Term and Long-Term Balances of Term Loan Schedule of Debt [Table Text Block] Settlement of convertible senior notes (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities ESPP Employee Stock [Member] Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Basic (in usd per share) Basic (loss) income per common share (in usd per share) Earnings Per Share, Basic Measurement Input Type [Axis] Measurement Input Type [Axis] Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Long-term debt, net Long-term debt, net Long-Term Debt, Excluding Current Maturities Award Type [Axis] Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Trade receivables, net Accounts Receivable, after Allowance for Credit Loss, Current Retained deficit Retained Earnings (Accumulated Deficit) Accrued procurement fees Accrued Procurement Fees Donated tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. The Company accrues estimated procurement fees due at the time tissues are received based on contractual agreements between the Company and the tissue banks and organ procurement organizations. Product and Service [Axis] Product and Service [Axis] Change in fair value of contingent consideration Change in valuation Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Debt instrument, unused borrowing capacity, amount Debt Instrument, Unused Borrowing Capacity, Amount Transaction bonuses recognized Business Combination, Separately Recognized Transactions, Liabilities Recognized Common Stock Common Stock [Member] Business combination, contingent consideration, liability Business Combination, Contingent Consideration, Liability Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Cover [Abstract] International Non-US [Member] Foreign currency translation Goodwill, Foreign Currency Translation, Gain (Loss) Equity Awards Adjustments Equity Awards Adjustments [Member] Total liabilities and stockholders’ equity Liabilities and Equity Realized investment gains (losses) Realized Investment Gains (Losses) Stock option Share-Based Payment Arrangement, Option [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Asset Class [Axis] Asset Class [Axis] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Tabular List, Table Tabular List [Table Text Block] Proceeds from financing insurance premiums Proceeds from Financing Insurance Premiums, Financing Activities Proceeds from Financing Insurance Premiums, Financing Activities Other income Other Nonoperating Income (Expense) Name Awards Close in Time to MNPI Disclosures, Individual Name Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Aortic stent grafts Aortic Stent Grafts [Member] Aortic Stent Grafts [Member] Payments related to sale of non-financial assets Payments Related To Sale of Non-financial Assets Payments Related To Sale of Non-financial Assets Surgical sealants Surgical Sealants [Member] Surgical Sealants [Member] Net loss (income) allocated to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted Long-Lived Asset, Class [Domain] Long-Lived Asset, Class [Domain] Settlement of convertible senior notes Stock Issued During Period, Value, Conversion of Convertible Securities Business Combination, Contingent Consideration, Type [Domain] Business Combination, Contingent Consideration, Type [Domain] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Other Other Products [Member] Other Products [Member] Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Table] Preferred stock $0.01 par value per share, 5,000 shares authorized, no shares issued Preferred Stock, Value, Issued Adjustment to Compensation: Adjustment to Compensation [Axis] Increase in worldwide revenue, measurement period Business Acquisition, Contingent Consideration Arrangements, Increase In Worldwide Revenue, Period Business Acquisition, Contingent Consideration Arrangements, Increase In Worldwide Revenue, Period Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Inventories and deferred preservation costs Increase (Decrease) in Deferred Preservation Costs and Inventories The increase (decrease) during the reporting period in deferred preservation costs and inventories, associated with underlying transactions that are classified as operating activities. Preservation costs consists primarily of direct labor and materials and indirect costs which are deferred until revenue is recognized upon shipment of the tissue to an implanting facility. Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Purchase Price Allocation Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) [Abstract] Net loss (income) allocated to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Basic In-process R&D In Process Research and Development [Member] Inventory [Line Items] Inventory [Line Items] Credit Facility [Axis] Credit Facility [Axis] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Total assets Assets, Fair Value Disclosure Discontinued Operations and Disposal Groups [Abstract] Name Measure Name Income Taxes Income Tax Disclosure [Text Block] Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Transfer Of Perclot Manufacturing Equipment Transfer Of Perclot Manufacturing Equipment [Member] Transfer Of PerClot Manufacturing Equipment [Member] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Aggregate amount of consideration transferred Fair value of total consideration transferred Business Combination, Consideration Transferred Additional Paid-In Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Contingent consideration revenue requirements as percent Business Acquisition, Contingent Consideration Arrangements, Increase In Worldwide Revenue As Percent Business Acquisition, Contingent Consideration Arrangements, Increase In Worldwide Revenue As Percent Indefinite-lived Intangible Assets [Axis] Intangible Asset, Indefinite-Lived, Class [Axis] Goodwill, impairment loss Goodwill, Impairment Loss Current portion of contingent consideration Contingent Consideration, Current, Fair Value Contingent Consideration, Current, Fair Value Principal payments on short-term notes payable Repayments of Short-Term Debt Name Trading Arrangement, Individual Name Cash and cash equivalents Cash and Cash Equivalent Company Selected Measure Amount Company Selected Measure Amount Depreciation and amortization Amortization expense Depreciation, Depletion and Amortization SOFR Secured Overnight Financing Rate (SOFR) [Member] Equity compensation (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Current assets: Assets, Current [Abstract] Non-PEO NEO Non-PEO NEO [Member] Baxter Achievement Of Worldwide Sales Baxter Achievement Of Worldwide Sales [Member] Baxter Achievement Of Worldwide Sales [Member] Foreign Currency Translation and Transactions Foreign Currency Transactions and Translations Policy [Policy Text Block] Entity Address, Address Line One Entity Address, Address Line One Income tax expense Income Tax Expense (Benefit) Foreign currency transaction gain (loss) Gain (Loss), Foreign Currency Transaction, before Tax Total cost of products and preservation services Cost of Product and Service Sold Acquired technology Technology-Based Intangible Assets [Member] Losses on inducement/extinguishment of debt Gain (Loss) on Induced Conversion of Convertible Debt Expense and Extinguishment of Debt Gain (Loss) on Induced Conversion of Convertible Debt Expense and Extinguishment of Debt Award Timing Method Award Timing Method [Text Block] Internal-use software, net Internal-use software, net Internal-Use Software, After Accumulated Amortization Internal-Use Software, After Accumulated Amortization Increase in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Maximum amount of future consideration payment Business Combination, Contingent Consideration, Range of Outcomes, Maximum, Amount Settlement of preexisting relationships and endospan option Noncash settlement of preexisting relationships and Endospan Option Business Combination, Noncash Settlement Of Pre-Existing Relationships Business Combination, Noncash Settlement Of Pre-Existing Relationships Other intangibles, net Other Intangible Assets, Net Net (loss) income Net (loss) income Net (loss) income Net (loss) income Net Income (Loss) Attributable to Parent Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Unamortized debt issuance costs Unamortized Debt Issuance Expense Statement [Table] Statement [Table] Endospan Loans Endospan Loans1 [Member] Endospan Loans1 Restatement Determination Date: Restatement Determination Date [Axis] Certificates of deposit Certificates of Deposit [Member] Interest income Investment Income, Interest Cash payment Debt Conversion, Converted Instrument, Amount Receivables Increase (Decrease) in Receivables LATAM Latin America Segment [Member] Latin America Segment Revenues: Revenues [Abstract] Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Diluted (loss) income per common share Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]